Twist Bioscience Corporation TWST Allowance for Doubtful Accounts Receivable (Current)
Allowance for Doubtful Accounts Receivable (Current) at other companies
Other financials
Where this comes from
Reported directly by Twist Bioscience Corporation in its filing.
Tagged under the XBRL concept us-gaap:AllowanceForDoubtfulAccountsReceivable.
The official record: Twist Bioscience Corporation’s 10-Q, filed May 4, 2026, on SEC EDGAR. View the filing →
Ask your AI about Twist Bioscience Corporation's allowance for doubtful accounts receivable (current).
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Twist Bioscience Corporation's allowance for doubtful accounts receivable (current)?
- Twist Bioscience Corporation (TWST) reported allowance for doubtful accounts receivable (current) of $500K in Q1 2026.
- How has Twist Bioscience Corporation's allowance for doubtful accounts receivable (current) changed year-over-year?
- Twist Bioscience Corporation's allowance for doubtful accounts receivable (current) decreased by 28.6% year-over-year, from $700K to $500K.
- What is the long-term trend for Twist Bioscience Corporation's allowance for doubtful accounts receivable (current)?
- Over 4 years (2020 to 2025), Twist Bioscience Corporation's allowance for doubtful accounts receivable (current) has grown at a 13.2% compound annual growth rate (CAGR), from $365K to $600K.
- What does allowance for doubtful accounts receivable (current) mean?
- This is the valuation allowance for current receivables that are considered uncollectible due to disputes, bankruptcy, or other non-payment issues. It serves as a buffer against potential losses from customer defaults. It is a critical indicator of the health of the company's accounts receivable portfolio.